Enovis Q2 sales up 8% to $429M; raises full-year guidance on organic growth and margin expansion

Enovis CORP

2023-Q2 EPS reported -$0.61 revenue$834,653,000

Q2 net sales $429M, +8% YoY; organic sales per day growth 9%.
Reconstructive segment grew 18% (17% organic); Prevention & Recovery grew 4%.
Net loss from continuing ops $0.27 per share; adjusted EPS $0.61.
Full-year 2023 guidance raised: organic revenue growth now 7-7.5% (prev 6-7%), adjusted EBITDA $262-270M.
Adjusted EBITDA margin improved 110bps to 15.3% of sales.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Enovis CORP reported the second quarter ended June 30, 2023 results: revenue $429 million, EPS net loss from continuing operations of $0.27 per share. Guidance raised.

Period: the second quarter ended June 30, 2023
Revenue: $429 million
EPS: net loss from continuing operations of $0.27 per share
Guidance: raised
Result: reported results

Exact text from the filing

Enovis’ second quarter net sales of $429 million grew 8% from the same quarter a year ago, including 9% organic sales per day growth, and reflecting a 0.7% sales days headwind which was slightly offset by currency and recent acquisitions.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Enovis CORP filing history →

Source: SEC EDGAR

accession 0001420800-23-000021

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.